Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1151 | 967 | 1311 | 1370 | 2255 | 3294 |
Fund Return | 15.08% | -3.3% | 31.11% | 11.05% | 17.66% | 12.66% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UTI Liquid Cash Inst FortnightlyDiv | 211.09B | 6.07 | 6.17 | - | ||
UTI Liquid Inst Quarterly Div | 211.09B | 6.12 | 6.20 | - | ||
UTI Liquid Cash Inst Growth Dir | 211.09B | 6.20 | 6.30 | 6.42 | ||
UTI Liquid Cash Inst Daily DRIP Dir | 211.09B | 3.80 | 3.10 | 4.26 | ||
UTI Liquid Cash Inst M Div Dir | 211.09B | 6.17 | 6.26 | 5.19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UTI Childrens Career Balanced Plan | 47.21B | 10.54 | 8.91 | 9.08 | ||
UTI Childrens Career Balanced Dir | 47.21B | 10.73 | 9.14 | 9.28 | ||
UTI CCP Advantage Dividend | 12B | 15.08 | 11.05 | 12.66 | ||
UTI CCP Advantage Fund GrowthDi | 12B | 16.16 | 12.27 | 13.67 | ||
UTI CCP Advantage Fund IncomeDi | 12B | 16.16 | 12.28 | 13.67 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ICICI Bank | INE090A01021 | 8.01 | 1,300.95 | +1.79% | |
HDFC Bank | INE040A01034 | 7.92 | 1,785.60 | +2.29% | |
Infosys | INE009A01021 | 5.40 | 1,889.70 | -0.66% | |
Bharti Airtel | INE397D01024 | 4.63 | 1,578.75 | +0.60% | |
Axis Bank | INE238A01034 | 3.24 | 1,155.90 | +1.18% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review